Cargando…
Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells
Angiogenesis, the formation of new blood vessels, is an essential step for cancer progression, but antiangiogenic therapies have shown limited success. Therefore, a better understanding of the effects of antiangiogenic treatments on endothelial cells is necessary. In this study, we evaluate the chan...
Autores principales: | Norton, Kerri-Ann, Han, Zheyi, Popel, Aleksander S, Pandey, Niranjan B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164292/ https://www.ncbi.nlm.nih.gov/pubmed/25228815 http://dx.doi.org/10.2147/OTT.S65055 |
Ejemplares similares
-
An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia
por: Norton, Kerri-Ann, et al.
Publicado: (2017) -
Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis
por: Norton, Kerri-Ann, et al.
Publicado: (2016) -
Sunitinib: the antiangiogenic effects and beyond
por: Hao, Zhonglin, et al.
Publicado: (2016) -
The balance of proangiogenic and antiangiogenic VEGFA isoforms regulate follicle development
por: McFee, Renee M., et al.
Publicado: (2012) -
Lymphatic endothelial cells support tumor growth in breast cancer
por: Lee, Esak, et al.
Publicado: (2014)